MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1158/1078-0432.ccr-24-1553

Медицинская библиотека · Clinical cancer research : an official journal of the American Association for Cancer Research · 2025

Hormone Receptor-Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast Cancers.

Rios-Hoyo Alejandro, Xiong Kaitlyn, Dai Jiawei, Yau Christina, Marczyk Michal, Garcia-Milian Rolando, Wolf Denise M, Huppert Laura A, Nanda Rita, Hirst Gillian L, Cobain Erin F, van 't Veer Laura J, Esserman Laura J, Pusztai Lajos

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: The MammaPrint (MP) prognostic assay categorizes breast cancers into high- and low-risk subgroups, and the high-risk group can be further subdivided into high-1 (MP-H1), and very high-risk high-2 (MP-H2). The aim of this analysis was to assess clinical and molecular differences between the hormone receptor-positive (HR+)/HER2-negative MP-H1, -H2, and triple-negative (TN) MP-H1 and -H2 cancers.

EXPERIMENTAL

DESIGN

Pretreatment gene expression data from 742 HER2-negative breast cancers enrolled in the I-SPY2 neoadjuvant trial were used. Prognostic risk categories were assigned using the MP assay. Transcriptional similarities across the four receptor and prognostic groups were assessed using principal component analyses and by identifying differentially expressed genes. We also examined pathologic complete response rates and event-free survivals by risk group.

RESULTS

Principal component analysis showed that HR+/MP-H2 tumors clustered with TN/MP-H2 cancers. Only 125 genes showed differential expression between the HR+/MP-H2 and TN/MP-H2 cancers, whereas 1,465 genes were differentially expressed between HR+/MP-H2 and -H1. Gene set analysis revealed similarly high expression of cell cycle, DNA repair, and immune infiltration-related pathways in HR+/MP-H2 and TN/MP-H2 cancers. HR+/MP-H2 cancers also showed low estrogen receptor-related gene expression. Pathologic complete response rates were similarly high in TN/MP-H2 and HR+/MP-H2 cancers (42% vs. 30.5%; P = 0.11), and MP-H2 cancers with residual cancer had similarly poor event-free survival regardless of estrogen receptor status.

CONCLUSIONS

In conclusion, HR+/MP-H2 cancers closely resemble TN breast cancers in transcriptional and clinical features and benefit from similar treatment strategies.

Для цитирования: Rios-Hoyo Alejandro, Xiong Kaitlyn, Dai Jiawei, Yau Christina, Marczyk Michal, Garcia-Milian Rolando, Wolf Denise M, Huppert Laura A, Nanda Rita, Hirst Gillian L, Cobain Erin F, van 't Veer Laura J, Esserman Laura J, Pusztai Lajos. Hormone Receptor-Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast Cancers.. Clinical cancer research : an official journal of the American Association for Cancer Research. 2025. DOI: 10.1158/1078-0432.ccr-24-1553.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.